References
- WoolfCJMannionRJNeuropathic pain: aetiology, symptoms, mechanisms, and managementLancet19993531959196410371588
- CostiganMScholzJWoolfCJNeuropathic pain: a maladaptive response of the nervous system to damageAnnu Rev Neurosci20093213219400724
- ArgoffCEKatzNBackonjaMTreatment of postherpetic neuralgia: a review of therapeutic optionsJ Pain Symptom Manage20042839641115471658
- LindsayTJRodgersBCSavathVHettingerKTreating diabetic peripheral neuropathic painAm Fam Physician20108215115820642268
- DothAHHanssonPTJensenMPTaylorRSThe burden of neuropathic pain: a systematic review and meta-analysis of health utilitiesPain201014933834420227832
- JohnsonRWZoster-associated pain: what is known, who is at risk and how can it be managed?Herpes200714Suppl 2303417939893
- BaderMSMcKinseyDSViral infections in the elderly. The challenges of managing herpes zoster, influenza, and RSVPostgrad Med2005118454816329530
- DworkinRHGnannJWOaklanderALRajaSNSchmaderKEWhitleyRJDiagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgiaJ Pain200891 Suppl 1S37S4418166464
- Vander StratenMCarrascoDLeePTyringSKReduction of postherpetic neuralgia in herpes zosterJ Cutan Med Surg2001540941611907852
- BouhassiraDChassanyOGaillatJPatient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practicePain201215334234922138256
- O’ConnorABDworkinRHTreatment of neuropathic pain: an overview of recent guidelinesAm J Med2009122Suppl 10S22S32
- American Pain FoundationTreatment options for post-herpetic neuralgia (long-term nerve pain) Available at: http://www.painfoundation.org/learn/pain-conditions/shingles/treatment-options-phn.htmlAccessed on May 4, 2012
- Depomed IncDepomed announces US Food and Drug Administration approval of Gralise™ (gabapentin) once-daily tablets for treatment of post-herpetic neuralgia Available at: http://investor.depomedinc.com/phoenix.zhtml?c=97276&p=irol-newsArticle_pf&ID=1521435Accessed May 4, 2012
- Neurontin [package insert]New York, NYPfizer Inc2009
- SinghDKennedyDHThe use of gabapentin for the treatment of postherpetic neuralgiaClin Ther20032585288912852705
- BockbraderHNWescheDMillerRChapelSJaniczekNBurgerPA comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentinClin Pharmacokinet20104966166920818832
- SangCNSathyanarayanaRCarterFJSweeneyMExtended release for the once-daily treatment of post herpetic neuralgiaPoster presented at the International Association for the Study of Pain, 13th World Congress on PainAugust 29–September 2, 2010Montreal, Canada
- RowbothamMHardenNStaceyBBernsteinPMagnus-MillerLGabapentin for the treatment of postherpetic neuralgia: a randomized controlled trialJAMA1998280183718429846778
- GordiTHouEKasichayanulaSBernerBPharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjectsClin Ther20083090991618555937
- RiceASMatonSPostherpetic Neuralgia Study GroupGabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled studyPain20019421522411690735
- RowbothamMHardenNStaceyBBernsteinPMagnus-MillerLGabapentin for the treatment of postherpetic neuralgiaJAMA1998280183718429846778
- EdelsbergJSLordCOsterGSystematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgiaAnn Pharmacother2011451483149022085778
- IrvingGJensenMCramerMEfficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trialClin J Pain20092518519219333167
- SweeneyMSathyanarayanaREffect of prior exposure to immediate-release α2-δligands on the efficacy and adverse event profile of once-daily gabapentin for the treatment of postherpetic neuralgiaPoster presented at the 63rd Annual Meeting of the American Academy of NeurologyApril 9–16, 2011Honolulu, HI
- SweeneyMSathyanarayanaREfficacy and tolerability of once-daily gabapentin for the treatment of postherpetic neuralgia in patients at least 65 years oldPoster presented at the 34th Annual Meeting of the Society of General Internal MedicineMay 4–7, 2011Phoenix, AZ